Highest-Volume Intravitreal Injection (Anti-VEGF) Surgeons in Vermont (2026 update)
6 Vermont providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in 2024. The top 10 by case volume are below — the full ranked list, CSV export and competitor-payment intel are available with a DocVol subscription ($199/mo, cancel anytime).
Database refreshed July 2026Live NPPES registryⓘ sources
| # | Surgeon | Location | Medicare cases (2024) |
|---|---|---|---|
| 1 | Michelle Young, MD, FRCSC | South Burlington, VT | 1,748 |
| 2 | Brian Kim, MD | Burlington, VT | 1,711 |
| 3 | David Weissgold, M.D. | South Burlington, VT | 1,526 |
| 4 | John Hinkle, M.D. | South Burlington, VT | 929 |
| 5 | Robert Raut, MD | Burlington, VT | 911 |
| 6 | David Terrell, M.D., PH.D. | Brattleboro, VT | 320 |
Frequently asked questions
- How many surgeons perform Intravitreal Injection (Anti-VEGF) in Vermont?
- 6 Vermont providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in CY2024. CMS suppresses providers with 10 or fewer Medicare patients, so the true count is somewhat higher.
- Where does this data come from?
- CMS Medicare Physician & Other Practitioners (fee-for-service Part B claims, CY2024, released May 2026) and CMS Open Payments. Both are official U.S. federal datasets.
- Does this include all of a surgeon's cases?
- No — it covers traditional Medicare only (no Medicare Advantage, commercial, or Medicaid claims). Absolute volumes undercount total practice, but the ranking of high- vs low-volume surgeons is a strong targeting signal.